<?xml version="1.0" encoding="UTF-8"?><!-- generator="wordpress/2.3.1" -->
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	>
<channel>
	<title>Comments on: Exelixis as a Platform Company</title>
	<link>http://www.hammerstockblog.com/exelixis-as-a-platform-company/</link>
	<description>Biotech stock reviews</description>
	<pubDate>Sat, 19 May 2012 10:25:47 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.3.1</generator>
		<item>
		<title>By: 1 Raindrop</title>
		<link>http://www.hammerstockblog.com/exelixis-as-a-platform-company/#comment-328</link>
		<dc:creator>1 Raindrop</dc:creator>
		<pubDate>Thu, 04 Sep 2008 15:11:06 +0000</pubDate>
		<guid>http://www.hammerstockblog.com/exelixis-as-a-platform-company/#comment-328</guid>
		<description>&lt;strong&gt;Biotech Platforms...&lt;/strong&gt;

It is interesting to see the notion of tech platforms play out in other fields. Specifically, the biotech field is all abuzz on platforms. For example Exelixis' oncology platform built on kinase inhibitors....</description>
		<content:encoded><![CDATA[<p><strong>Biotech Platforms&#8230;</strong></p>
<p>It is interesting to see the notion of tech platforms play out in other fields. Specifically, the biotech field is all abuzz on platforms. For example Exelixis&#8217; oncology platform built on kinase inhibitors&#8230;.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

